PVCT: Provectus Biopharmaceuticals, Inc. Stock

by  •  • Comments Off on PVCT: Provectus Biopharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 71.45
Enterprise Value ($M) 73.67
Book Value ($M) -5.07
Book Value / Share -0.01
Price / Book -14.10
NCAV ($M) -5.09
NCAV / Share -0.01
Price / NCAV -14.05

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -5.00
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.11
Current Ratio 0.11

Balance Sheet (mrq) ($M)
Current Assets 0.65
Assets 0.67
Liabilities 5.74
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.62
Operating Income -3.95
Net Income -4.76
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -3.28
Cash from Investing 0.00
Cash from Financing 2.75

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-06 13D/A Pershing Edward 8.03 60.87
08-14 13G Morris Jeffrey Allen 11.30 4.52

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-16 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)

Similar Companies
PTCHF – PureTech Health plc PTNT – Palatin Technologies, Inc.
PTPI – Petros Pharmaceuticals, Inc. PXMD – PaxMedica, Inc.
PXXLF – Poxel S.A.


Financial data and stock pages provided by
Fintel.io